Home
/
Immunome Inc.
/
Financials
/
Quarterly
Immunome Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Immunome Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 6, 2025
Q2
2025
Jun 30, 2025
$4.02M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$2.93M
May 12, 2025
Q3
2025
Sep 30, 2024
$2.91M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$2.36M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$1.03M
May 12, 2025
Q3
2024
Sep 30, 2023
$3.57M
Nov 13, 2024
Q2
2024
Jun 30, 2023
$4.26M
Aug 12, 2024
Q1
2024
Mar 31, 2023
$2.36M
May 14, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($57.46M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($43.40M)
Aug 6, 2025
Q3
2025
Jun 30, 2025
($43.40M)
Nov 6, 2025
Q3
2025
Mar 31, 2025
($41.64M)
Nov 6, 2025
Q1
2025
Mar 31, 2025
($41.64M)
May 12, 2025
Q2
2025
Mar 31, 2025
($41.64M)
Aug 6, 2025
Q3
2025
Sep 30, 2024
($47.10M)
Nov 6, 2025
Q3
2025
Jun 30, 2024
($36.12M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($36.12M)
Aug 6, 2025
Q3
2025
Mar 31, 2024
($129.49M)
Nov 6, 2025
Q2
2025
Mar 31, 2024
($129.49M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($129.49M)
May 12, 2025
Q3
2024
Sep 30, 2023
($4.35M)
Nov 13, 2024
Q3
2024
Jun 30, 2023
($5.56M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($5.56M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($4.27M)
May 14, 2024
Q3
2024
Mar 31, 2023
($4.27M)
Nov 13, 2024
Q2
2024
Mar 31, 2023
($4.27M)
Aug 12, 2024
Q3
2023
Sep 30, 2022
($8.53M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($8.92M)
Aug 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($60.14M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($46.48M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($44.64M)
May 12, 2025
Q3
2025
Sep 30, 2024
($50.52M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($40.01M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($132.30M)
May 12, 2025
Q3
2024
Sep 30, 2023
($4.63M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($5.77M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($4.47M)
May 14, 2024
Q3
2023
Sep 30, 2022
($8.53M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($8.93M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($11.65M)
May 5, 2023
Q3
2022
Sep 30, 2021
($7.72M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($5.74M)
Aug 5, 2022
Q1
2022
Mar 31, 2021
($3.90M)
May 12, 2022
Q3
2021
Sep 30, 2020
($2.82M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($2.72M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($2.66M)
May 12, 2021
Q3
2020
Sep 30, 2019
($2.72M)
Nov 16, 2020